CMB 0.00% 0.4¢ cambium bio limited

Ann: Kyocera completes Progenza Due Diligence, page-18

  1. 503 Posts.
    lightbulb Created with Sketch. 149
    "The question now is whether RGS' very weak financial position will force it to grant an exclusive licence to Kyocera for Progenza in Japan at a rock bottom price"

    Just reminded me of the "talking to multiple interested parties" line that was repeatably rolled out. Assuming that should still be the case given the overall better position now that prior.

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.